Cultivation Capital Life Sciences

Check this investor

21 founders have viewed this investor
Fund vehicles on file

Cultivation Capital Life Sciences has 2 venture fund vehicles on file with the SEC, run from St. Louis, Missouri, with first sales running from 2022 to 2025. 3 Form D notices, originals and amendments, have been filed for them, the first on April 19, 2023 and the latest on March 26, 2026. Together they have taken in $61,250,000 from 62 investor positions, most recently on April 4, 2025. The smallest investment any of them will accept is $250,000. 2 vehicles are still showing room to take more.

Vehicles22 still open
Closed$61.3M$61,250,000
Target$140M$140,000,000
Since last close565dApril 4, 2025
Vehicle Vintage Target Closed Remaining First sale Days Min check LPs Status
Cultivation Capital Life Sciences Fund IV, LP
Limited Partnership · Delaware-organised
2025 $40M $6.5M $33.5M April 4, 2025 565 $250K 0 open amended
Cultivation Capital Tech Fund IV, LP
Limited Partnership · Delaware-organised
2022 $100M $54.8M $45.3M February 16, 2022 1,708 $250K 62 open amended
People named in the fund filings

The filings for these vehicles name 16 people and entities, with the role each filing gives.

Registered adviser

No SEC adviser registration found under this name.

Related investors
All investors with a sourced record →
Vetting this investor? Get the free Snapshot → Order Full Report on Cultivation Capital Life Sciences → Get warm-intro paths to Cultivation Capital Life Sciences → See how VCs use MentionFox →

Tools for this story

Each opens in a new tab, filled in for Cultivation Capital Life Sciences. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/investors/cultivation-capital-life-sciences
Last updated 2026-03-26
Cultivation Capital Life Sciences: venture fund vehicles on file. MentionFox, 2026-03-26. https://mentionfox.com/investors/cultivation-capital-life-sciences
Public profile · MentionFox — investor research, warm-intro mapping, and full reports.